4//SEC Filing
RUTHERFORD BILL B 4
Accession 0001209191-23-007165
CIK 0000860730other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:22 PM ET
Size
20.4 KB
Accession
0001209191-23-007165
Insider Transaction Report
Form 4
RUTHERFORD BILL B
CFO and EVP
Transactions
- Exercise/Conversion
Stock Appreciation Right
2023-02-01−37,000→ 0 totalExercise: $68.96Exp: 2025-02-04→ Common Stock (37,000 underlying) - Exercise/Conversion
Common Stock
2023-02-01$69.58/sh+27,000$1,878,660→ 146,527 total - Sale
Common Stock
2023-02-03$258.19/sh−30,000$7,745,568→ 81,632 total - Exercise/Conversion
Stock Appreciation Right
2023-02-01−27,000→ 19,100 totalExercise: $69.58Exp: 2026-01-29→ Common Stock (27,000 underlying) - Tax Payment
Common Stock
2023-02-01$261.46/sh−34,895$9,123,647→ 111,632 total - Exercise/Conversion
Common Stock
2023-02-01$68.96/sh+37,000$2,551,520→ 119,527 total
Holdings
- 18,640(indirect: By Trust)
Common Stock
- 10,000(indirect: By LLC)
Common Stock
- 40,000(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.67 to $258.54, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.
- [F3]The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.
Documents
Issuer
HCA Healthcare, Inc.
CIK 0000860730
Entity typeother
Related Parties
1- filerCIK 0001216850
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:22 PM ET
- Size
- 20.4 KB